Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates (Q28374993)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

R N Jones

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic Microbiology and Infectious Disease

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

19-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Tetracyclines, molecular and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

In vitro activities of two glycylcyclines against gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

In-vitro activity of two glycylcyclines against enterococci resistant to other agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality Control Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Evolution and spread of tetracycline resistance determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Characterization of the tetracycline resistance gene of plasmid pT181 of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

In vitro activities of two glycylcyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

Minocycline as an alternative antistaphylococcal agent

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900092-9

7 January 2021

10.1016/S0732-8893(99)00092-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference